Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Current corticosteroid pulse therapy is not very effective for severe rapidly progressive alopecia areata.

A woman had meningitis caused by mixed connective tissue disease, not an infection.

Terbinafine effectively treated kerion celsi despite disrupted immune responses.

A woman with dermatomyositis improved after treatment for neck panniculitis, suggesting similar treatment for related conditions.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

TB lymphadenitis can occur in people with weakened immune systems, like those with SLE.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.

Candida auris uses the immune response to colonize hair follicles.

TGF-β1 and TNF-α contribute to lung damage after radiation.

The patient had paraneoplastic pemphigus without mucosal involvement.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

Immunoadsorption successfully treated a man's resistant polymyositis.

GRF is not safe for tubal occlusion.

Cyclosporine effectively treated a woman's stubborn skin condition.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

Follicular mucinosis can be an early sign of aggressive mycosis fungoides.

More research is needed to understand and manage rheumatoid arthritis better.

The review says skin conditions with sterile pustules need more research for better treatments.

The case shows how hard it is to tell apart Multiple Autoimmune Syndrome from other similar autoimmune conditions, but correct diagnosis is key for treatment to work.

Benign follicular mucinosis involves immune cells attacking hair follicles.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

Early diagnosis and targeted anti-inflammatory treatments can improve outcomes in androgenetic alopecia with perifollicular inflammation and fibrosis.

Upadacitinib effectively treats pyoderma gangrenosum.

Fluconazole is the preferred treatment for deep skin infections in immunocompromised patients.

Platelet-released growth factors can reduce inflammation in joint disease.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

A mouse model for studying scleroderma in chronic graft-versus-host disease was successfully created.